Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapy

CAS OpenIR > 膜生物学国家重点实验室

	Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapy
发表期刊	Oncogene (2018) 37:4941–4954
	2018
期号	37 页码:4941-4954
	Bo Zhu; Liming Tang; Shuyang Chen; Chengqian Yin; Shiguang Peng; Xin Li; Tongzheng Liu; Wei Liu; Changpeng Han; Lukasz Stawski; Zhi-Xiang Xu; Zhou GB(周光飚); Xiang Chen; Xiumei Gao; Colin R.Goding; Nan Xu; Rutao Cui; Peng Cao
文献类型	期刊论文
条目标识符	http://ir.ioz.ac.cn/handle/000000/13524
专题	膜生物学国家重点实验室
推荐引用方式 GB/T 7714	Bo Zhu,Liming Tang,Shuyang Chen,et al. Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapy[J]. Oncogene (2018) 37:4941–4954,2018(37):4941-4954.
APA	Bo Zhu.,Liming Tang.,Shuyang Chen.,Chengqian Yin.,Shiguang Peng.,...&Peng Cao.(2018).Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapy.Oncogene (2018) 37:4941–4954(37),4941-4954.
MLA	Bo Zhu,et al."Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapy".Oncogene (2018) 37:4941–4954 .37(2018):4941-4954.